Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
January 18, 2018 08:30 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus,...
Clinical Genomics Pathology Inc. Receives Accreditation from College of American Pathologists (CAP) for Liquid Biopsy Lab
December 19, 2017 08:30 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of liquid biopsy cancer testing solutions, today announced the Accreditation Committee of the College of...
Roy Davis Joins Liquid Biopsy Company Clinical Genomics Board of Directors
December 12, 2017 08:30 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the appointment of Roy Davis...
Clinical Genomics and Quest Diagnostics announce FDA 510(K) clearance of InSure® ONE™
November 13, 2017 08:00 ET
|
Clinical Genomics
At-home collection, one-day fecal immunochemical test that meets American Cancer Society guidelines and HEDIS quality measures for lower gastrointestinal bleeding screening programs A number of...
Clinical Genomics Working with Leading Cancer Center to Evaluate Colvera™ in Patients with Colorectal Cancer
October 19, 2017 08:00 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer testing solutions, today announced the initiation of a new rectal cancer therapy monitoring study...
QIAGEN and Clinical Genomics partner on liquid biopsies to monitor patients for recurrence of colorectal cancer
August 21, 2017 16:10 ET
|
Clinical Genomics
HILDEN, Germany and GERMANTOWN, Md. and BRIDGEWATER, N.J., Aug. 21, 2017 (GLOBE NEWSWIRE) -- QIAGEN (NASDAQ:QGEN) (Frankfurt Prime Standard:QIA) and Clinical Genomics, a private company developing...
Data Presented at ASCO Annual 2017 Shows Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer
June 09, 2017 08:30 ET
|
Clinical Genomics
BRIDGEWATER, N.J., June 09, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, presented data demonstrating the utility of...
Clinical Genomics to Present Data at ASCO Supporting Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer
May 31, 2017 08:00 ET
|
Clinical Genomics
BRIDGEWATER, N.J., May 31, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, today announced that data demonstrating the...
Clinical Genomics Announces Participation in Fortified Provider Network and MultiPlan
March 08, 2017 08:00 ET
|
Clinical Genomics
BRIDGEWATER, N.J., March 08, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced it has signed agreements...
Clinical Genomics to Present Data at ASCO GI Supporting Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer
January 18, 2017 08:00 ET
|
Clinical Genomics
BRIDGEWATER, N.J., Jan. 18, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company marketing innovative diagnostic tools for colorectal cancer, today announced that data demonstrating the...